Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;56(2):78-85.
doi: 10.4314/gmj.v56i2.4.

Feasibility and reliability of measuring muscle stiffness in Parkinson's Disease using MyotonPRO device in a clinical setting in Ghana

Mary W Agoriwo  1   2 , Paul E Muckelt  3   4 , Cynthia O Yeboah  1 , Beatrice E A Sankah  3   4 , Sandra Agyapong-Badu  5 , Albert Akpalu  6 , Maria Stokes  3   4   7
Affiliations

Feasibility and reliability of measuring muscle stiffness in Parkinson's Disease using MyotonPRO device in a clinical setting in Ghana

Mary W Agoriwo et al. Ghana Med J. 2022 Jun.

Abstract

Objectives: To examine the feasibility and within-session reliability of Myoton technology to measure muscle stiffness objectively in people with Parkinson's disease in an outpatient setting.

Design: An exploratory quantitative study design was used.

Setting: The study was conducted in the outpatient physiotherapy department of a Teaching Hospital in Ghana. Participants were recruited from three sites.

Participants: Thirty adults with Parkinson's disease over 18 years with increased tone (muscle stiffness) and at Hoehn and Yahr Stages I-III were studied. Persons with severe comorbidities were excluded.

Intervention: There was no intervention before testing. The MyotonPRO device measured the mechanical properties of the biceps brachii, flexor carpi radialis and tibialis anterior muscles in a relaxed supine position. The probe applied mechanical impulses to the skin, eliciting tissue oscillations. The muscles' three parameters (stiffness, non-neural tone and elasticity) were recorded bilaterally. The reliability of two sets (of 5 impulses) of Myoton data on all three muscles was examined.

Results: All 30 participants (66.3±8.9 years) were recruited and tested within eight weeks. Intraclass correlation coefficients (ICC 3,2) were above 0.92 for biceps brachii and tibialis anterior and above 0.86 for flexor carpi radialis.

Conclusion: The MyotonPRO was reliable for measuring two sets of data within the same session, indicating that only one set of measurements is needed. The technique is feasible and easy to use in a clinical setting in Ghana, with the potential to assess the effect of medical and physiotherapy interventions on muscles in people with Parkinson's disease.

Funding: M.S discloses a grant from the Science and Technology Facilities Council Impact Acceleration Account at the University of Southampton to support this collaborative research (no personal finance received). All other authors, M.W.A, P.E.M, C.O.Y, B.E.A.S, S.A.-B, and A.A have no financial disclosure.

Keywords: Assessment; Feasibility; Muscle stiffness; Parkinson's disease; Reliability.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1
Figure 1
MyotonPRO device in use for assessing the mechanical properties of the Biceps Brachii muscle.
Figure 2
Figure 2
Waveforms demonstrating muscle oscillation and its relative displacement (S) and velocity (V) in relation to the oscillation acceleration (a).
See this image and copyright information in PMC

References

    1. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591–1601. - PubMed
    1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5(6):525–535. - PubMed
    1. Pont-Sunyer C, Hotter A, Gaig C, et al. The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PDStudy) Mov Disord. 2015;30(2):229–237. - PubMed
    1. Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Engl J Med. 2003;348(14):1356–1364. - PubMed
    1. Lee CS, Samii A, Sossi V, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann. Neurol: Official Journal of the American Neurological Association and the Child Neurology Society. 2000;47(4):493–503. - PubMed

LinkOut - more resources